Counterpoint Mutual Funds’s Integra LifeSciences IART Stock Holding History

Counterpoint Mutual Funds’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,267	Closed	-$500K	–	389
2025 Q4	$500K	Buy	40,267 +3,080	+8%	+$40.9K	0.04%	177
2025 Q3	$533K	Buy	37,187 +3,368	+10%	+$46.1K	0.04%	86
2025 Q2	$415K	Buy	+33,819	New	+$491K	0.04%	136
2024 Q4	–	Sell	-15,548	Closed	-$283K	–	347
2024 Q3	$283K	Buy	15,548 +7,044	+83%	+$163K	0.05%	141
2024 Q2	$248K	Buy	+8,504	New	+$252K	0.06%	121

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Counterpoint Mutual Funds's IART Position: Q1 2026 in Review

Counterpoint Mutual Funds sold out of Integra LifeSciences (IART) in Q1 2026, closing a stake of 40,267 shares — an estimated $500K sold.

Counterpoint Mutual Funds first reported a position in IART in Q2 2024 and held it in 5 quarters. The position peaked at $533K in Q3 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Counterpoint Mutual Funds reported no remaining Integra LifeSciences position as of Q1 2026 after selling out during the quarter.
Counterpoint Mutual Funds sold 40,267 Integra LifeSciences shares in Q1 2026, an estimated $500K.
Counterpoint Mutual Funds first reported a position in Integra LifeSciences in Q2 2024 and held it in 5 quarters.
Counterpoint Mutual Funds's Integra LifeSciences position peaked at $533K in Q3 2025.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.